Ryan A Maddox1, Marissa K Person2, Janis E Blevins2, Joseph Y Abrams2, Brian S Appleby2, Lawrence B Schonberger2, Ermias D Belay2. 1. From the National Center for Emerging and Zoonotic Infectious Diseases (R.A.M., M.K.P., J.Y.A., L.B.S., E.D.B.), Centers for Disease Control and Prevention, Atlanta, GA; and National Prion Disease Pathology Surveillance Center (J.E.B., B.S.A.), Case Western Reserve University, Cleveland, OH. rmaddox@cdc.gov. 2. From the National Center for Emerging and Zoonotic Infectious Diseases (R.A.M., M.K.P., J.Y.A., L.B.S., E.D.B.), Centers for Disease Control and Prevention, Atlanta, GA; and National Prion Disease Pathology Surveillance Center (J.E.B., B.S.A.), Case Western Reserve University, Cleveland, OH.
Abstract
OBJECTIVE: To report the incidence of prion disease in the United States. METHODS: Prion disease decedents were retrospectively identified from the US national multiple cause-of-death data for 2003-2015 and matched with decedents in the National Prion Disease Pathology Surveillance Center (NPDPSC) database through comparison of demographic variables. NPDPSC decedents with neuropathologic or genetic test results positive for prion disease for whom no match was found in the multiple cause-of-death data were added as cases for incidence calculations; those with cause-of-death data indicating prion disease but with negative neuropathology results were removed. Age-specific and age-adjusted average annual incidence rates were then calculated. RESULTS: A total of 5,212 decedents were identified as having prion disease, for an age-adjusted average annual incidence of 1.2 cases per million population (range 1.0 per million [2004 and 2006] to 1.4 per million [2013]). The median age at death was 67 years. Ten decedents were <30 years of age (average annual incidence of 6.2 per billion); only 2 of these very young cases were sporadic forms of prion disease. Average annual incidence among those ≥65 years of age was 5.9 per million. CONCLUSIONS: Prion disease incidence can be estimated by augmenting mortality data with the results of neuropathologic and genetic testing. Cases <30 years of age were extremely rare, and most could be attributed to exogenous factors or the presence of a genetic mutation. Continued vigilance for prion diseases in all age groups remains prudent.
OBJECTIVE: To report the incidence of prion disease in the United States. METHODS:Prion disease decedents were retrospectively identified from the US national multiple cause-of-death data for 2003-2015 and matched with decedents in the National Prion Disease Pathology Surveillance Center (NPDPSC) database through comparison of demographic variables. NPDPSC decedents with neuropathologic or genetic test results positive for prion disease for whom no match was found in the multiple cause-of-death data were added as cases for incidence calculations; those with cause-of-death data indicating prion disease but with negative neuropathology results were removed. Age-specific and age-adjusted average annual incidence rates were then calculated. RESULTS: A total of 5,212 decedents were identified as having prion disease, for an age-adjusted average annual incidence of 1.2 cases per million population (range 1.0 per million [2004 and 2006] to 1.4 per million [2013]). The median age at death was 67 years. Ten decedents were <30 years of age (average annual incidence of 6.2 per billion); only 2 of these very young cases were sporadic forms of prion disease. Average annual incidence among those ≥65 years of age was 5.9 per million. CONCLUSIONS:Prion disease incidence can be estimated by augmenting mortality data with the results of neuropathologic and genetic testing. Cases <30 years of age were extremely rare, and most could be attributed to exogenous factors or the presence of a genetic mutation. Continued vigilance for prion diseases in all age groups remains prudent.
Authors: Emma Jones; Holger Hummerich; Emmanuelle Viré; James Uphill; Athanasios Dimitriadis; Helen Speedy; Tracy Campbell; Penny Norsworthy; Liam Quinn; Jerome Whitfield; Jacqueline Linehan; Zane Jaunmuktane; Sebastian Brandner; Parmjit Jat; Akin Nihat; Tze How Mok; Parvin Ahmed; Steven Collins; Christiane Stehmann; Shannon Sarros; Gabor G Kovacs; Michael D Geschwind; Aili Golubjatnikov; Karl Frontzek; Herbert Budka; Adriano Aguzzi; Hata Karamujić-Čomić; Sven J van der Lee; Carla A Ibrahim-Verbaas; Cornelia M van Duijn; Beata Sikorska; Ewa Golanska; Pawel P Liberski; Miguel Calero; Olga Calero; Pascual Sanchez-Juan; Antonio Salas; Federico Martinón-Torres; Elodie Bouaziz-Amar; Stéphane Haïk; Jean-Louis Laplanche; Jean-Phillipe Brandel; Phillipe Amouyel; Jean-Charles Lambert; Piero Parchi; Anna Bartoletti-Stella; Sabina Capellari; Anna Poleggi; Anna Ladogana; Maurizio Pocchiari; Serena Aneli; Giuseppe Matullo; Richard Knight; Saima Zafar; Inga Zerr; Stephanie Booth; Michael B Coulthart; Gerard H Jansen; Katie Glisic; Janis Blevins; Pierluigi Gambetti; Jiri Safar; Brian Appleby; John Collinge; Simon Mead Journal: Lancet Neurol Date: 2020-09-16 Impact factor: 44.182
Authors: Vıctor Manuel Gómez-López; Amparo Viramontes-Pintos; Miguel Ángel Ontiveros-Torres; Linda Garcés-Ramírez; Fidel de la Cruz; Ignacio Villanueva-Fierro; Marely Bravo-Muñoz; Charles R Harrington; Sandra Martínez-Robles; Petra Yescas; Parménides Guadarrama-Ortíz; Mario Hernandes-Alejandro; Francisco Montiel-Sosa; Mar Pacheco-Herrero; José Luna-Muñoz Journal: J Alzheimers Dis Date: 2021 Impact factor: 4.472
Authors: Liliana Sánchez-González; Ryan A Maddox; Larissa C Lewis; Janis E Blevins; Elizabeth J Harker; Brian S Appleby; Marissa K Person; Lawrence B Schonberger; Ermias D Belay; Chas DeBolt; Kathryn H Lofy Journal: JAMA Netw Open Date: 2020-10-01
Authors: Eric Vallabh Minikel; Konrad J Karczewski; Hilary C Martin; Beryl B Cummings; Nicola Whiffin; Daniel Rhodes; Jessica Alföldi; Richard C Trembath; David A van Heel; Mark J Daly; Stuart L Schreiber; Daniel G MacArthur Journal: Nature Date: 2020-05-27 Impact factor: 49.962
Authors: Nicholas Brennecke; Ignazio Cali; Tze How Mok; Helen Speedy; Laszlo L P Hosszu; Christiane Stehmann; Laura Cracco; Gianfranco Puoti; Thomas W Prior; Mark L Cohen; Steven J Collins; Simon Mead; Brian S Appleby Journal: Viruses Date: 2021-09-08 Impact factor: 5.048